SVS — Svas Biosana SpA Income Statement
0.000.00%
Last trade - 00:00- €42.09m
- €70.69m
- €120.31m
- 81
- 94
- 76
- 98
Annual income statement for Svas Biosana SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 76 | 81.1 | 97.2 | 118 | 120 |
| Cost of Revenue | |||||
| Gross Profit | 23.1 | 24.1 | 26.4 | 28.9 | 32.4 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 71 | 75.3 | 91 | 110 | 111 |
| Operating Profit | 5.09 | 5.77 | 6.26 | 8.57 | 9.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.21 | 4.02 | 4.66 | 6.8 | 8.01 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.51 | 3.16 | 3.57 | 5.13 | 5.88 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.51 | 3.16 | 3.57 | 5.12 | 5.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.51 | 3.16 | 3.57 | 5.12 | 5.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.565 | 0.702 | 0.806 | 1.08 | 1.22 |
| Dividends per Share |